5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Expansion of a PBPK model to predict disposition in pregnant women of drugs cleared via multiple CYP enzymes, including CYP2B6, CYP2C9 and CYP2C19.

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Conducting PK studies in pregnant women is challenging. Therefore, we asked if a physiologically-based pharmacokinetic (PBPK) model could be used to predict the disposition in pregnant women of drugs cleared by multiple CYP enzymes.

          Related collections

          Author and article information

          Journal
          Br J Clin Pharmacol
          British journal of clinical pharmacology
          1365-2125
          0306-5251
          Mar 2014
          : 77
          : 3
          Affiliations
          [1 ] Department of Pharmaceutics, University of Washington, Seattle, WA, USA; Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.
          Article
          10.1111/bcp.12207
          4371535
          23834474
          2cdf3915-9fca-4349-a131-f6813d9f389b
          © 2013 The British Pharmacological Society.
          History

          CYP2B6,CYP2C19,CYP2C9,PBPK,pharmacokinetics,pregnancy
          CYP2B6, CYP2C19, CYP2C9, PBPK, pharmacokinetics, pregnancy

          Comments

          Comment on this article